Vislyfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vislyfa, covering 2026-08-18 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Vislyfa (ranibizumab) — Lupin Europe GmbH
1 regulatory and trial event tracked for Vislyfa, covering 2026-08-18 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Vislyfa (ranibizumab) — Lupin Europe GmbH